Saregama India Limited Stocks

359.7Last Updated 27.04.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

₹ 707.24M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
359.7
Key Takeaways

Risk factor

Limited trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Saregama India Limited engages in the sound recording and publishing business in India and internationally. The company operates through Music, Films/TV Serials, and Publication segments. The Music segment manufactures and sells music storage devices, such as carvaan, mini carvaan, music cards, audio compact discs, digital versatile discs, etc., as well as deals with related music rights. The Films/TV Serials segment produces, sells, telecasts, and broadcasts films, TV serials, and pre-recorded programs, as well as deals in film rights. The Publication segment publishes OPEN, a weekly current affairs magazine. The company was formerly known as Gramophone Company of India Ltd. The company was founded in 1901 and is headquartered in Mumbai, India. Saregama India Limited is a subsidiary of Composure Services Private Limited.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Very favourable
7/7

The average target price of SAREGAMA.NS is 562 and suggests 56% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks